News headlines about Hill-Rom Holdings (NYSE:HRC) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Hill-Rom Holdings earned a daily sentiment score of 0.20 on Accern’s scale. Accern also gave news stories about the medical technology company an impact score of 46.3186543416107 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Several equities analysts recently issued reports on HRC shares. Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a report on Friday, October 27th. KeyCorp restated a “buy” rating and issued a $82.00 target price on shares of Hill-Rom Holdings in a report on Tuesday, October 17th. Stifel Nicolaus restated a “buy” rating and issued a $84.00 target price on shares of Hill-Rom Holdings in a report on Sunday, July 30th. Needham & Company LLC dropped their target price on shares of Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a report on Friday, July 28th. Finally, ValuEngine upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating in a report on Thursday, November 16th. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $88.57.
Shares of Hill-Rom Holdings (NYSE HRC) traded up $0.42 during midday trading on Friday, hitting $83.53. 190,267 shares of the stock traded hands, compared to its average volume of 510,392. Hill-Rom Holdings has a 52-week low of $52.58 and a 52-week high of $84.65. The firm has a market capitalization of $5,490.00, a price-to-earnings ratio of 21.53, a P/E/G ratio of 1.77 and a beta of 1.19. The company has a quick ratio of 1.34, a current ratio of 1.77 and a debt-to-equity ratio of 1.55.
Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.05. Hill-Rom Holdings had a net margin of 4.87% and a return on equity of 20.27%. The firm had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. During the same quarter in the prior year, the business earned $1.18 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. sell-side analysts forecast that Hill-Rom Holdings will post 4.26 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 15th will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.72 annualized dividend and a dividend yield of 0.86%. Hill-Rom Holdings’s dividend payout ratio is currently 36.18%.
In other news, SVP Andreas G. Frank sold 6,870 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $77.48, for a total transaction of $532,287.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at $1,293,993.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the company’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total transaction of $306,689.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This report was originally published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://transcriptdaily.com/2017/11/25/hill-rom-holdings-hrc-getting-somewhat-positive-media-coverage-study-shows.html.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.